2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine
![]() |
- $1066 - $1174.2
- Product name: 2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine
- CAS: 690269-87-5
- MF: C11H15N5O4
- MW: 281.27
- EINECS:
- MDL Number:MFCD25542506
- Synonyms:2-AMino-9-(2-C-Methyl-β-D-ribofuranosyl)-9H-purine;9-(2-C-Methyl-beta-D-ribofuranosyl)-9H-purin-2-amine;(2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol;9H-Purin-2-amine, 9-(2-C-methyl-β-D-ribofuranosyl)-;2-Amino-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine;2-Ami no-9-(2-b-C-methyl-β-D-ribofuranosyl)-9H-purine
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number690269875
- Product description(2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol
- Packaging1g
- Price$1174.2
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM138819
- Product description(2R,3R,4R,5R)-2-(2-amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol 97%
- Packaging1g
- Price$1066
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD70000612
- Product description(2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol 97%
- Packaging1g
- Price$1140
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 690269875 | (2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol | 1g | $1174.2 | 2021-12-16 | Buy |
Chemenu | CM138819 | (2R,3R,4R,5R)-2-(2-amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol 97% | 1g | $1066 | 2021-12-16 | Buy |
Crysdot | CD70000612 | (2R,3R,4R,5R)-2-(2-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol 97% | 1g | $1140 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|